Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Breau M, et al
FEBS Open Bio
In the United States: The FDA has not approved BPC-157 for therapeutic use
Scientific research on NAFLD & IV glutathione showed remarkable results: ALT Reduction : Liver inflammation markers decreased significantly (p=0.014) Fat Reduction : Controlled attenuation parameter (CAP) values improved in responders Metabolic Benefits : Triglycerides, non-esterified fatty acids, and ferritin levels all decreased These results were achieved with just 300mg daily oral glutathione
US$ 25.27
US$ 20.22
US$ 25.72
US$ 29.78
